Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $123.55 | 8 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bioventus LLC | $42.99 | 2 | $0 (2017) |
| Amgen Inc. | $30.00 | 2 | $0 (2018) |
| Abbott Laboratories | $20.88 | 2 | $0 (2017) |
| Mallinckrodt LLC | $17.84 | 1 | $0 (2017) |
| Lilly USA, LLC | $11.84 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2018 | $17.24 | 1 | Amgen Inc. ($17.24) |
| 2017 | $106.31 | 7 | Bioventus LLC ($42.99) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/03/2018 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: Inflammation | ||||||
| 11/30/2017 | Mallinckrodt LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 11/06/2017 | Abbott Laboratories | DRG leads (Device) | Food and Beverage | In-kind items and services | $10.44 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 11/06/2017 | Abbott Laboratories | DRG leads (Device) | Food and Beverage | In-kind items and services | $10.44 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 10/11/2017 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: Inflammation | ||||||
| 09/28/2017 | Bioventus LLC | GELSYN 3 (Device) | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: Not Applicable | ||||||
| 08/16/2017 | Lilly USA, LLC | FORTEO (Drug) | Food and Beverage | In-kind items and services | $11.84 | General |
| Category: Bone Muscle Joint | ||||||
| 06/14/2017 | Bioventus LLC | Exogen (Device) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: Not Applicable | ||||||
About Dr. Robert Schoen, M.D
Dr. Robert Schoen, M.D is a Foot and Ankle Surgery healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1447253935.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Schoen, M.D has received a total of $123.55 in payments from pharmaceutical and medical device companies, with $17.24 received in 2018. These payments were reported across 8 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($123.55).
Practice Information
- Specialty Foot and Ankle Surgery
- Location Austin, TX
- Active Since 05/27/2005
- Last Updated 07/06/2009
- Taxonomy Code 207XX0004X
- Entity Type Individual
- NPI Number 1447253935
Products in Payments
- Enbrel (Biological) $30.00
- GELSYN 3 (Device) $24.66
- DRG leads (Device) $20.88
- Exogen (Device) $18.33
- ACTHAR (Biological) $17.84
- FORTEO (Drug) $11.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.